Therefore, we inferred that the gene fusion PTGFRN-NOTCH2 in this study appeared to be more like a loss-of-function mutations, consistent with those recently described for myeloid leukemia [46], head and neck squamous cell carcinoma [47], [48]. This evidence concerns the gene NOTCH2 and head and neck squamous cell carcinoma.